| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244216 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 10 Pages |
Abstract
Conclusion: This regimen of radiotherapy plus capecitabine is well tolerated and is more convenient than protracted venous infusion of 5-FU. The pathologic response rate is comparable to our previous experience using protracted venous infusion 5-FU for LARC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sunil M.D., Nora A. M.D., John M. M.D., Miguel A. M.D., Robert A. M.D., Prajnan M.D., Marc E. M.D., George J. M.D., Paulo M. M.D., Cathy M.D., Thomas D. M.D., Christopher H. M.D., Barry W. M.D., Jeffrey Ph.D., Saroj M.D., Stanley R. M.D., Edward H. M.D.,